Home
ACE Reports
All Specialties All Specialties All Specialties Arthroplasty Arthroplasty Arthroplasty Evidence Based Medicine Evidence Based Medicine Evidence Based Medicine Foot & Ankle Foot & Ankle Foot & Ankle General Orthopaedics General Orthopaedics General Orthopaedics Hand & Wrist Hand & Wrist Hand & Wrist Metabolic Disorders Metabolic Disorders Metabolic Disorders Osteoarthritis Osteoarthritis Osteoarthritis Pediatric Orthopaedics Pediatric Orthopaedics Pediatric Orthopaedics Peri-Operative Peri-Operative Peri-Operative Physical Therapy & Rehab Physical Therapy & Rehab Physio & Rehab Shoulder & Elbow Shoulder & Elbow Shoulder & Elbow Spine Spine Spine Sports Medicine Sports Medicine Sports Medicine Trauma Trauma Trauma Tumour Tumour Tumour Author Interviews Author Interviews Author Interview Conference Report Conference Report Conference Reports
Original Content
News
Multimedia
About
Search
Home
ACE Reports
Arthroplasty Evidence Based Medicine Foot & Ankle General Orthopaedics Hand & Wrist Metabolic Disorders Osteoarthritis Pediatric Orthopaedics Peri-Operative Physical Therapy & Rehab Shoulder & Elbow Spine Sports Medicine Trauma Tumour Author Interviews Conference Report
Original Content
News
Multimedia
About
Search
Previous Ace Report Low-intensity pulsed ultrasound not cost-effective following IM nailing of fresh tibial fracture Next Ace Report Higher AP laxity with irradiated versus non-irradiated hamstring allograft in DB ACL reconstruction
Ace Report Cover
Trauma
No significant decrease in SSI rate with prophylactic cefazolin in below-knee implant removal
Reprints
Cite This
Reprints
Cite This
AceReport Image
Trauma
No significant decrease in SSI rate with prophylactic cefazolin in below-knee implant removal
Verified
This report has been verified by one or more authors of the original publication.
JAMA. 2017 Dec 26;318(24):2438-2445
Contributing Authors

JC Goslings B van Dijkman H van den Berg JP Schots MG Dijkgraaf T Schepers SA Dingemans M Backes JM Hoogendoorn P Joosse ED Ritchie WH Roerdink NL Sosef IJB Spijkerman BA Twigt AH van der Veen RN van Veen J Vermeulen DI Vos J Winkelhagen

477 patients who had previously undergone internal fixation for a fracture of the foot, ankle, or lower leg were randomized to either prophylactic cefazolin or saline during routine implant removal. The primary outcome was the development of surgical site infection within 4 weeks of implant removal. Overall, no significant difference in the rate of surgical site infection was observed between the cefazolin group and the saline group.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with

OR
Forgot Password?
OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. No significant decrease in SSI rate with prophylactic cefazolin in below-knee implant removal . ACE Report. 2018;8(5):14. Available from: https://myorthoevidence.com/AceReport/Report/no-significant-decrease-in-ssi-rate-with-prophylactic-cefazolin-in-below-knee-implant-removal

Copy Citation
Share this Ace Report